Inmedix hosts 2nd annual charity golf tournament to support kids with arthritis.

Inmedix pays all costs; 100% of player fees go to Seattle Children’s Hospital pediatric rheumatology.

Our annual Inmedix event is conducted to remind our community that children also get arthritis and that we need to keep working hard to combat and prevent it.”

— Andrew J Holman MD

NORMANDY PARK, WA, USA, August 22, 2018 /EINPresswire.com/ -- As part of its commitment to combating autoimmune diseases, Inmedix today announced that it will host its second annual Inmedix Golf Tournament on Monday, August 27, 2018 at the Rainier Golf & Country Club in Seattle, Washington. Inmedix raised $11,000 for Seattle Children’s Hospital pediatric rheumatology at its inaugural event in 2017.

Inmedix wishes to thank the Seattle Mariners, Pro Golf Discount and iHeartMedia KJR (950 AM, “Sports Radio 950”) for their generous support in 2017, and again, in 2018.

With 100% of all player fees benefiting Seattle Children’s Hospital pediatric rheumatology, the tournament tees off with a 1 p.m. shotgun start. The tournament will feature closest to the pin, longest drive and other contests and prizes, followed by a Caribbean-style dinner and steel-drum band.

“New immuno-autonomic breakthroughs have been reported for adults with autoimmune diseases,” said Andrew J. Holman, MD, founder and CEO of Inmedix and Clinical Associate Professor of Medicine (rheumatology) at the University of Washington. "However, we wish we could do more for children afflicted by these serious, destructive diseases. Our annual Inmedix event is conducted to remind our community that children also get arthritis and that we need to keep working hard to combat and prevent it.”

Registration is $125 per player, and open to both individuals and foursomes. Golfers can register by mailing name, handicap and checks payable to “Seattle Children’s Hospital” to:

Inmedix
Attn: 2018 Golf Tournament Registration
17837 First Avenue South, #6
Normandy Park, WA 98148

For more information, please contact Rae Marie Gleason at raemarie.gleason@inmedix.com (714-423-4863), or Andrew J. Holman, MD, at andrew.holman@inmedix.com (206-412-5347).

About Inmedix, Inc and its subsidiary, Inmedix UK, Ltd.

Seattle-based medtech/biotech Inmedix, Inc. and its UK subsidiary are committed to engaging in world class research to discover innovative solutions for pressing healthcare needs related to the impact of stress modulated within the brain by the autonomic nervous system (ANS). The Inmedix ANS Neuroscan™ is leading applications of next-generation heart rate variability (HRV) as an informative diagnostic, therapeutic, digital health and health economic tool in autoimmune disease. Beginning with rheumatoid arthritis (RA), psoriatic arthritis (PsA), systemic lupus erythematosus (SLE) and ankylosing spondylitis (AS) in adults, the company hopes to enhance current therapeutic outcomes through complimentary optimization of individual autonomic (ANS) profile so that patients will no longer cycle through the disappointment of one failed therapeutic intervention after another.

For more information, visit http://www.inmedix.com

Rae Marie Gleason
Education Program Director, Inmedix, Inc.
714-423-4863
email us here

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry, Science, Technology

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release